Prostate Cancer

Dana-Farber Cancer Institute Handbook

Edited by

  • Arthur Skarin, MD, FACP, FCCP, Associate Professor of Medicine, Harvard Medical School, Boston, MA, USA; Senior Attending Physician, Dana-Farber Cancer Institute, Boston, MA, USA
  • William Oh, MD, Clinical Director, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Assistant Professor of Medicine, Harvard Medical School, Boston, MA, USA
  • John Logue, MB, MRCP, FRCR, Consultant Medical Oncologist, Christie Hospital NHS Trust, Manchester, UK

Written by highly eminent authors, Prostate Cancer - a handbook in the Dana-Farber Cancer Institute series - is produced in full color and is richly illustrated throughout, providing a review of each cancer including its incidence, epidemiology, etiology and histopathology, together with the clinical features. Diagnostic studies and current clinical and pathological staging are also given. Detailed tables are provided with histopathological classification, diagnostic studies and, when important, prognostic factors. Current therapies are also discussed in detail, together with useful algorithms to aid treatment decisions. Practical issues relating to management are also given such as dealing with systemic and mucocutaneous reactions to chemotherapy, including alopecia, fatigue and extravasation.
View full description

Audience

The book is aimed at trainee oncologists and general physicians who manage cancer patients outside of specialist centers.

 

Book information

  • Published: June 2007
  • Imprint: MOSBY
  • ISBN: 978-0-7234-3436-8


Table of Contents

Introduction

The role of molecular probes and other markers in the diagnosis and characterization of malignancy

Prostate cancer: epidemiology, histology, diagnosis and staging

Prostate cancer therapy

Systemic and mucocutaneous reactions to chemotherapy